{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:27:07Z","timestamp":1780622827367,"version":"3.54.1"},"reference-count":47,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2018]]},"DOI":"10.7883\/yoken.jjid.2017.089","type":"journal-article","created":{"date-parts":[[2017,12,25]],"date-time":"2017-12-25T17:17:24Z","timestamp":1514222244000},"page":"51-57","source":"Crossref","is-referenced-by-count":43,"title":["Data Mining and Machine Learning Algorithms Using &lt;i&gt;IL28B&lt;\/i&gt; Genotype and Biochemical Markers Best Predicted Advanced Liver Fibrosis in Chronic Hepatitis C"],"prefix":"10.7883","volume":"71","author":[{"given":"Hend Ibrahim","family":"Shousha","sequence":"first","affiliation":[{"name":"Endemic Medicine Department, Faculty of Medicine, Cairo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abubakr Hussein","family":"Awad","sequence":"additional","affiliation":[{"name":"Computer Science Department, Faculty of Computers and Information, Cairo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia Abdelhamid","family":"Omran","sequence":"additional","affiliation":[{"name":"Endemic Medicine Department, Faculty of Medicine, Cairo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayada Mohamed","family":"Elnegouly","sequence":"additional","affiliation":[{"name":"Endemic Medicine Department, Faculty of Medicine, Cairo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahasen","family":"Mabrouk","sequence":"additional","affiliation":[{"name":"Endemic Medicine Department, Faculty of Medicine, Cairo University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4631","reference":[{"key":"1","unstructured":"1. De Minicis S, Marzioni M, Saccomanno S, et al. Cellular and molecular mechanisms of hepatic fibrogenesis leading to liver cancer. Transl Gastrointest Cancer. 2012;1:88-94."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Eslam M, Hashem AM, Leung R, et al. Interferon-\u03bb rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease. Nat Commun. 2015;6:6422.","DOI":"10.1038\/ncomms7422"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Waked I, Doss W, El-Sayed MH, et al. The current and future disease burden of chronic hepatitis C virus infection in Egypt. Arab J of Gastroentrol. 2014;15:45-52.","DOI":"10.1016\/j.ajg.2014.04.003"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134:1655-69.","DOI":"10.1053\/j.gastro.2008.03.003"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Noureddin M, Wright EC, Alter HJ, et al. Association of <i>IL28B<\/i> genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis. Hepatology. 2013;58:1548-57.","DOI":"10.1002\/hep.26506"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fateh A, Aghasadeghi MR, Keyvani H, et al. High resolution melting curve assay for detecting rs12979860 <i>IL28B<\/i> polymorphisms involved in response of Iranian patients to chronic hepatitis C treatment. Asian Pac J Cancer Prev. 2015;16:1873-80.","DOI":"10.7314\/APJCP.2015.16.5.1873"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Derbala M, Rizk NM, Al-Kaabi S, et al. The predictive value of <i>IL28B<\/i> rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients. Virology. 2013;444:292-300.","DOI":"10.1016\/j.virol.2013.06.025"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Rembeck K, Lagging M. Impact of <i>IL28B<\/i>, <i>ITPA<\/i> and <i>PNPLA3<\/i> genetic variants on therapeutic outcome and progression of hepatitis C virus infection. Pharmacogenomics. 2015;16:1179-88.","DOI":"10.2217\/pgs.15.65"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Fateh A, Aghasadeghi M, Siadat SD, et al. Comparison of three different methods for detection of <i>IL28<\/i> rs12979860 polymorphisms as a predictor of treatment outcome in patients with hepatitis C virus. Osong Public Health Res Perspect. 2016;7:83-9.","DOI":"10.1016\/j.phrp.2015.11.004"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tanaka Y, Nishida N, Sugiyama M, et al. Genome-wide association of <i>IL28B<\/i> with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet. 2009;41:1105-9.","DOI":"10.1038\/ng.449"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ge D, Fellay J, Thompson AJ, et al. Genetic variation in <i>IL28B<\/i> predicts hepatitis C treatment-induced viral clearance. Nature. 2009;461:399-401.","DOI":"10.1038\/nature08309"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ragheb MM, Nemr NA, Kishk RM, et al. Strong prediction of virological response to combination therapy by <i>IL28B<\/i> gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4. Liver Int. 2014;34:890-5.","DOI":"10.1111\/liv.12321"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Abdelwahab SF, Zakaria Z, Allam WR, et al. Interleukin 28B. rs12979860 genotype does not affect hepatitis C viral load in Egyptians with genotype 4 chronic infection. Arch Virol. 2015;160:2833-7.","DOI":"10.1007\/s00705-015-2555-3"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. O&apos;Brien TR, Lang Kuhs KA, Pfeiffer RM. Subgroup differences in response to 8 weeks of ledipasvir\/sofosbuvir for chronic hepatitis C. Open Forum Infect Dis. 2014;1:ofu110.","DOI":"10.1093\/ofid\/ofu110"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sulkowski MS, Gardiner DF, Rodriguez-Torres M, et al. Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. N Engl J Med. 2014;370:211-21.","DOI":"10.1056\/NEJMoa1306218"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Petta S, Cabibbo G, Enea M, et al. Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C. Hepatology. 2014;59:1692-705.","DOI":"10.1002\/hep.27010"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Alboraie M, Khairy M, Elsharkawy M, et al. Value of Egy-Score in diagnosis of significant, advanced hepatic fibrosis and cirrhosis compared to aspartate aminotransferase-to-platelet ratio index, FIB-4 and Forns\u2019 index in chronic hepatitis C virus. Hepatol Res. 2015;45:560-70.","DOI":"10.1111\/hepr.12385"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Khairy M, Abdel-Rahman M, El-Raziky M, et al. Non-invasive prediction of hepatic fibrosis in patients with chronic HCV based on the routine pre-treatment workup. Hepat Mon. 2012;12:e6718.","DOI":"10.5812\/hepatmon.6718"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Yosry A, Fouad R, Alem SA, et al. FibroScan, APRI, FIB4, and GUCI: role in prediction of fibrosis and response to therapy in Egyptian patients with HCV infection. Arab J Gastroenterol. 2016;17:78-83.","DOI":"10.1016\/j.ajg.2016.05.002"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Witten IH, Frank E, Hall MA. Data Mining: Practical Machine Learning Tools and Techniques, 3rd ed. Burlington, MA: Morgan Kaufmann; 2011.","DOI":"10.1016\/B978-0-12-374856-0.00001-8"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 2008;48:835-47.","DOI":"10.1016\/j.jhep.2008.02.008"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23. De Ledinghen V, Vergniol J. Transient elastography (FibroScan). Gastroenterol Clin Biol. 2008;32:Suppl 1:58-67.","DOI":"10.1016\/S0399-8320(08)73994-0"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343-50.","DOI":"10.1053\/j.gastro.2004.11.018"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25. El-Awady MK, Bader El-Din NG, Tabll A, et al. <i>IL28B<\/i> polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients. World J Gastroenterol. 2013;19:290-8.","DOI":"10.3748\/wjg.v19.i2.290"},{"key":"25","doi-asserted-by":"crossref","unstructured":"26. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518-26.","DOI":"10.1053\/jhep.2003.50346"},{"key":"26","doi-asserted-by":"crossref","unstructured":"27. Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV co-infection. Hepatology. 2006;43:1317-25.","DOI":"10.1002\/hep.21178"},{"key":"27","doi-asserted-by":"crossref","unstructured":"28. Brazdil P, Giraud-Carrier C, Soares C, et al. Metalearning: Applications to Data Mining (Cognitive Technologies). Berlin, Germany: Springer; 2009.","DOI":"10.1007\/978-3-540-73263-1"},{"key":"28","doi-asserted-by":"crossref","unstructured":"29. Yada N, Kudo M, Kawada N, et al. Noninvasive diagnosis of liver fibrosis: utility of data mining of both ultrasound elastography and serological findings to construct a decision tree. Oncology. 2014;87:Suppl 1:63-72.","DOI":"10.1159\/000368147"},{"key":"29","doi-asserted-by":"crossref","unstructured":"30. P\u00e1r A, P\u00e1r G, Tornai I, et al. <i>IL28B<\/i> and <i>IL10R<\/i> -1087 polymorphisms are protective for chronic genotype 1 HCV infection and predictors of response to interferon-based therapy in an East-Central European cohort. BMC Res Notes. 2014;7:12.","DOI":"10.1186\/1756-0500-7-12"},{"key":"30","doi-asserted-by":"crossref","unstructured":"31. El-Awady MK, Mostafa L, Tabll AA, et al. Association of <i>IL28B<\/i> SNP with progression of Egyptian HCV genotype 4 patients to end stage liver disease. Hepat Mon. 2012;12:271-7.","DOI":"10.5812\/hepatmon.835"},{"key":"31","doi-asserted-by":"crossref","unstructured":"32. Zekri AR, Salama H, Medhat E, et al. <i>IL28B<\/i> rs12979860 gene polymorphism in Egyptian patients with chronic liver disease infected with HCV. Asian Pac J Cancer Prev. 2014;15:7213-8.","DOI":"10.7314\/APJCP.2014.15.17.7213"},{"key":"32","doi-asserted-by":"crossref","unstructured":"33. Thomas DL, Thio CL, Martin MP, et al. Genetic variation in <i>IL28B<\/i> and spontaneous clearance of hepatitis C virus. Nature. 2009;461:798-801.","DOI":"10.1038\/nature08463"},{"key":"33","unstructured":"34. El-Bendary M, Neamatallah MA, Abd El-Maksoud M, et al. Interleukin 28B polymorphism predicts treatment outcome among Egyptian patients infected with HCV genotype 4. Hepato-gastroenterology. 2015;62:947-50."},{"key":"34","doi-asserted-by":"crossref","unstructured":"35. Shaker O, Rashad A, Abd El-Aziz G, et al. Is rs8099917 polymorphism of <i>IL-28B<\/i> gene a good predictor of response to therapy of HCV than rs12979860? An Egyptian study. Cell Biochem Biophys. 2015;71:307-14.","DOI":"10.1007\/s12013-014-0199-7"},{"key":"35","doi-asserted-by":"crossref","unstructured":"36. Knapp S, Zakaria Z, Hashem M, et al. Influence of <i>IFNL3<\/i>. rs12979860 and <i>IFNL4<\/i>.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians. Hepatol Int. 2015;9:251-7.","DOI":"10.1007\/s12072-015-9619-z"},{"key":"36","doi-asserted-by":"crossref","unstructured":"37. Sato M, Kondo M, Tateishi R, et al. Impact of <i>IL28B<\/i> genetic variation on HCV-induced liver fibrosis, inflammation, and steatosis: a meta-analysis. PLoS One. 2014;9:e91822.","DOI":"10.1371\/journal.pone.0091822"},{"key":"37","doi-asserted-by":"crossref","unstructured":"38. Youssef SS, Abbas EA, Abd el Aal AM, et al. Association of <i>IL28B<\/i> polymorphism with fibrosis, liver inflammation, gender respective natural history of hepatitis C virus in Egyptian patients with genotype 4. J Interferon Cytokine Res. 2014;34:22-7.","DOI":"10.1089\/jir.2013.0036"},{"key":"38","doi-asserted-by":"crossref","unstructured":"39. Hashem S, Esmat G, Elakel W, et al. Accurate prediction of advanced liver fibrosis using the decision tree learning algorithm in chronic hepatitis C Egyptian patients. Gastroenterol Res Pract. 2016;2016:2636390.","DOI":"10.1155\/2016\/2636390"},{"key":"39","doi-asserted-by":"crossref","unstructured":"40. Bonnard P, Elsharkawy A, Zalata K, et al. Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt. J Viral Hepat. 2015;22:245-53.","DOI":"10.1111\/jvh.12285"},{"key":"40","doi-asserted-by":"crossref","unstructured":"41. El-Nakeeb NA, Helmy A, Saleh SA, et al. Comparison between FIB-4 index and Fibroscan as marker of fibrosis in chronic HCV infection in Egyptian patients. Open J Gastroenterol. 2014;4:383-91.","DOI":"10.4236\/ojgas.2014.412052"},{"key":"41","doi-asserted-by":"crossref","unstructured":"42. Atta MME, El-Sharkawy EH, Said E, et al. Assessment of eight non-invasive markers of liver fibrosis in Egyptian patients with chronic hepatitis C. Gastroenterol. 2011;140:S457.","DOI":"10.1016\/S0016-5085(11)61878-7"},{"key":"42","unstructured":"43. Rezaei-Darzi E, Farzadfar F, Hashemi-Meshkini A, et al. Comparison of two data mining techniques in labeling diagnosis to Iranian pharmacy claim dataset: artificial neural network (ANN) versus decision tree model. Arch Iran Med. 2014;17:837-43."},{"key":"43","unstructured":"44. Song Y, Lu Y. Decision tree methods: applications for classification and prediction. Shanghai Arch Psychiatry. 2015;27:130-5."},{"key":"44","doi-asserted-by":"crossref","unstructured":"45. Poon TC, Hui AY, Chan HL, et al. Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study. Clin Chem. 2005;51:328-35.","DOI":"10.1373\/clinchem.2004.041764"},{"key":"45","doi-asserted-by":"crossref","unstructured":"46. Barros RC, Winck AT, Machado KS, et al. Automatic design of decision-tree induction algorithms tailored to flexible-receptor docking data. BMC Bioinformatics. 2012;13:310.","DOI":"10.1186\/1471-2105-13-310"},{"key":"46","doi-asserted-by":"crossref","unstructured":"47. Bal M, Amasyali MF, Sever H, et al. Performance evaluation of the machine learning algorithms used in inference mechanism of a medical decision support system. Scientific World Journal. 2014;2014:137896.","DOI":"10.1155\/2014\/137896"},{"key":"47","doi-asserted-by":"crossref","unstructured":"48. Cao Y, Hu Z-D, Liu X-F, et al. An MLP classifier for prediction of HBV-induced liver cirrhosis using routinely available clinical parameters. Dis Markers. 2013;35:653-60.","DOI":"10.1155\/2013\/127962"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/71\/1\/71_JJID.2017.089\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T13:56:32Z","timestamp":1570542992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/71\/1\/71_JJID.2017.089\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2017.089","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}